THOMAS R STAAB II Insider Trading $BCRX BIOCRYST PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for THOMAS R STAAB II.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of THOMAS R STAAB II. THOMAS R STAAB II is Senior Vice President and CFO in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Chief Financial Officer in INSPIRE PHARMACEUTICALS INC ($ISPH) and Chief Financial Officer in LENSAR, Inc. ($LNSR).
THOMAS R STAAB II in BIOCRYST PHARMACEUTICALS INC
Trading Symbol: BCRXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of THOMAS R STAAB II: Senior Vice President and CFO
Holdings: 134,926 shares
Current Value: $765,030
Latest Transaction: Feb 25 2020
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of THOMAS R STAAB II in BIOCRYST PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BCRX, ISPH, LNSR
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 25 2020 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | A | 11.13 | 18,000 | 200,340 | 18,000 | |
Feb 19 2020 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | A | 11.13 | 31,500 | 350,595 | 31,500 | |
Dec 19 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | A | 3.23 | 165,000 | 532,950 | 165,000 | |
May 20 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 1.42 | 4,750 | 6,745 | 61,000 | |
May 20 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.45 | 2,500 | 18,625 | 125,176 | 127.7 K to 125.2 K (-1.96 %) |
May 20 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.72 | 7,250 | 55,970 | 127,676 | 134.9 K to 127.7 K (-5.37 %) |
May 20 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 1.42 | 4,750 | 6,745 | 134,926 | 130.2 K to 134.9 K (+3.65 %) |
May 16 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 1.42 | 4,750 | 6,745 | 65,750 | |
May 16 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 1.42 | 4,500 | 6,390 | 70,500 | |
May 16 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.92 | 7,250 | 57,420 | 130,176 | 137.4 K to 130.2 K (-5.28 %) |
May 16 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 1.42 | 4,750 | 6,745 | 137,426 | 132.7 K to 137.4 K (+3.58 %) |
May 16 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.62 | 4,500 | 34,290 | 132,676 | 137.2 K to 132.7 K (-3.28 %) |
May 16 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 1.42 | 4,500 | 6,390 | 137,176 | 132.7 K to 137.2 K (+3.39 %) |
May 13 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 5.51 | 9,750 | 53,723 | 131,250 | |
May 13 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 5.51 | 9,750 | 53,723 | 141,000 | |
May 13 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.76 | 9,750 | 75,660 | 132,676 | 142.4 K to 132.7 K (-6.85 %) |
May 13 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 5.51 | 9,750 | 53,723 | 142,426 | 132.7 K to 142.4 K (+7.35 %) |
May 13 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.63 | 9,750 | 74,393 | 132,676 | 142.4 K to 132.7 K (-6.85 %) |
May 13 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 5.51 | 9,750 | 53,723 | 142,426 | 132.7 K to 142.4 K (+7.35 %) |
May 06 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 5.51 | 9,000 | 49,590 | 150,750 | |
May 06 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 5.51 | 7,750 | 42,703 | 159,750 | |
May 06 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.75 | 9,000 | 69,750 | 132,676 | 141.7 K to 132.7 K (-6.35 %) |
May 06 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 5.51 | 9,000 | 49,590 | 141,676 | 132.7 K to 141.7 K (+6.78 %) |
May 06 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.30 | 7,750 | 56,575 | 132,676 | 140.4 K to 132.7 K (-5.52 %) |
May 06 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 5.51 | 7,750 | 42,703 | 140,426 | 132.7 K to 140.4 K (+5.84 %) |
Apr 08 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 5.51 | 7,500 | 41,325 | 167,500 | |
Apr 08 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.81 | 7,500 | 66,075 | 132,676 | 140.2 K to 132.7 K (-5.35 %) |
Apr 08 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 5.51 | 7,500 | 41,325 | 140,176 | 132.7 K to 140.2 K (+5.65 %) |
Jan 30 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 5.45 | 5,000 | 27,250 | 7,000 | |
Jan 30 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.85 | 5,000 | 49,250 | 128,426 | 133.4 K to 128.4 K (-3.75 %) |
Jan 30 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 5.45 | 5,000 | 27,250 | 133,426 | 128.4 K to 133.4 K (+3.89 %) |
Jan 03 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Payment of Exercise | F | 8.07 | 785 | 6,335 | 132,676 | 133.5 K to 132.7 K (-0.59 %) |
Dec 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | A | 7.06 | 235,000 | 1,659,100 | 235,000 | |
Dec 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.45 | 3,922 | 37,063 | 133,461 | 137.4 K to 133.5 K (-2.85 %) |
Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,500 | 13,230 | 28,305 | |
Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 7,000 | 26,460 | 31,805 | |
Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 5.45 | 5,000 | 27,250 | 12,000 | |
Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.66 | 3,500 | 33,810 | 137,383 | 140.9 K to 137.4 K (-2.48 %) |
Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,500 | 13,230 | 140,883 | 137.4 K to 140.9 K (+2.55 %) |
Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.08 | 7,000 | 63,560 | 137,383 | 144.4 K to 137.4 K (-4.85 %) |
Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 7,000 | 26,460 | 144,383 | 137.4 K to 144.4 K (+5.10 %) |
Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.41 | 5,000 | 47,050 | 137,383 | 142.4 K to 137.4 K (-3.51 %) |
Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 5.45 | 5,000 | 27,250 | 142,383 | 137.4 K to 142.4 K (+3.64 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 6,500 | 20,930 | 97,071 | |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 6,500 | 20,930 | 97,071 | |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 4,623 | 17,475 | 38,805 | |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 4,623 | 17,475 | 38,805 | |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 75 | 284 | 43,428 | |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 75 | 284 | 43,428 | |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.75 | 6,500 | 56,875 | 137,383 | 143.9 K to 137.4 K (-4.52 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.75 | 6,500 | 56,875 | 137,383 | 143.9 K to 137.4 K (-4.52 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 6,500 | 20,930 | 143,883 | 137.4 K to 143.9 K (+4.73 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 6,500 | 20,930 | 143,883 | 137.4 K to 143.9 K (+4.73 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.57 | 4,623 | 39,619 | 137,383 | 142 K to 137.4 K (-3.26 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.57 | 4,623 | 39,619 | 137,383 | 142 K to 137.4 K (-3.26 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 4,623 | 17,475 | 142,006 | 137.4 K to 142 K (+3.37 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 4,623 | 17,475 | 142,006 | 137.4 K to 142 K (+3.37 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.30 | 75 | 623 | 137,383 | 137.5 K to 137.4 K (-0.05 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.30 | 75 | 623 | 137,383 | 137.5 K to 137.4 K (-0.05 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 75 | 284 | 137,458 | 137.4 K to 137.5 K (+0.05 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 75 | 284 | 137,458 | 137.4 K to 137.5 K (+0.05 %) |
Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 2,302 | 8,702 | 43,503 | |
Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 11,113 | 35,784 | 103,571 | |
Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 672 | 2,164 | 114,684 | |
Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.30 | 2,302 | 19,107 | 137,383 | 139.7 K to 137.4 K (-1.65 %) |
Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 2,302 | 8,702 | 139,685 | 137.4 K to 139.7 K (+1.68 %) |
Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.09 | 11,113 | 89,904 | 137,383 | 148.5 K to 137.4 K (-7.48 %) |
Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 11,113 | 35,784 | 148,496 | 137.4 K to 148.5 K (+8.09 %) |
Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.00 | 672 | 5,376 | 137,383 | 138.1 K to 137.4 K (-0.49 %) |
Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 672 | 2,164 | 138,055 | 137.4 K to 138.1 K (+0.49 %) |
Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 215 | 692 | 115,356 | |
Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.00 | 215 | 1,720 | 137,383 | 137.6 K to 137.4 K (-0.16 %) |
Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 215 | 692 | 137,598 | 137.4 K to 137.6 K (+0.16 %) |
Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,500 | 13,230 | 45,805 | |
Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 7,356 | 23,686 | 115,571 | |
Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.96 | 3,500 | 27,860 | 137,383 | 140.9 K to 137.4 K (-2.48 %) |
Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,500 | 13,230 | 140,883 | 137.4 K to 140.9 K (+2.55 %) |
Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.78 | 7,356 | 57,230 | 137,383 | 144.7 K to 137.4 K (-5.08 %) |
Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 7,356 | 23,686 | 144,739 | 137.4 K to 144.7 K (+5.35 %) |
Oct 23 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,150 | 11,907 | 49,305 | |
Oct 23 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.45 | 3,150 | 23,468 | 137,383 | 140.5 K to 137.4 K (-2.24 %) |
Oct 23 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,150 | 11,907 | 140,533 | 137.4 K to 140.5 K (+2.29 %) |
Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 100 | 378 | 52,455 | |
Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 972 | 3,130 | 122,927 | |
Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 5,528 | 17,800 | 123,899 | |
Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,250 | 12,285 | 52,555 | |
Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.45 | 100 | 745 | 137,383 | 137.5 K to 137.4 K (-0.07 %) |
Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 100 | 378 | 137,483 | 137.4 K to 137.5 K (+0.07 %) |
Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.26 | 972 | 7,057 | 137,383 | 138.4 K to 137.4 K (-0.70 %) |
Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 972 | 3,130 | 138,355 | 137.4 K to 138.4 K (+0.71 %) |
Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.27 | 5,528 | 40,189 | 137,383 | 142.9 K to 137.4 K (-3.87 %) |
Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 5,528 | 17,800 | 142,911 | 137.4 K to 142.9 K (+4.02 %) |
Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.19 | 3,250 | 23,368 | 137,383 | 140.6 K to 137.4 K (-2.31 %) |
Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,250 | 12,285 | 140,633 | 137.4 K to 140.6 K (+2.37 %) |
Jan 23 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Payment of Exercise | F | 5.59 | 3,979 | 22,243 | 137,383 | 141.4 K to 137.4 K (-2.81 %) |
Jan 03 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Payment of Exercise | F | 4.91 | 852 | 4,183 | 141,362 | 142.2 K to 141.4 K (-0.60 %) |
Dec 22 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | A | 5.04 | 100,000 | 504,000 | 100,000 | |
Sep 05 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | A | 11.13 | 27,000 | 300,510 | 27,000 | |
May 24 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 4.73 | 7,750 | 36,658 | 4,000 | |
May 24 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Payment of Exercise | F | 5.24 | 6,996 | 36,659 | 142,214 | 149.2 K to 142.2 K (-4.69 %) |
May 24 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 4.73 | 7,750 | 36,658 | 149,210 | 141.5 K to 149.2 K (+5.48 %) |
Mar 22 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,250 | 12,285 | 55,805 | |
Mar 22 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.20 | 3,250 | 29,900 | 141,460 | 144.7 K to 141.5 K (-2.25 %) |
Mar 22 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,250 | 12,285 | 144,710 | 141.5 K to 144.7 K (+2.30 %) |
Mar 20 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 1.42 | 12,500 | 17,750 | 75,000 | |
Mar 20 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 23,955 | 90,550 | 59,055 | |
Mar 20 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Payment of Exercise | F | 8.80 | 12,308 | 108,310 | 141,460 | 153.8 K to 141.5 K (-8.00 %) |
Mar 20 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 1.42 | 12,500 | 17,750 | 153,768 | 141.3 K to 153.8 K (+8.85 %) |
Mar 20 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 23,955 | 90,550 | 141,268 | 117.3 K to 141.3 K (+20.42 %) |
Mar 14 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,250 | 12,285 | 83,010 | |
Mar 14 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.06 | 3,250 | 29,445 | 117,313 | 120.6 K to 117.3 K (-2.70 %) |
Mar 14 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,250 | 12,285 | 120,563 | 117.3 K to 120.6 K (+2.77 %) |
Mar 10 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 6,500 | 24,570 | 86,260 | |
Mar 10 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.65 | 3,250 | 28,113 | 117,313 | 120.6 K to 117.3 K (-2.70 %) |
Mar 10 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.20 | 3,250 | 26,650 | 120,563 | 123.8 K to 120.6 K (-2.62 %) |
Mar 10 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 6,500 | 24,570 | 123,813 | 117.3 K to 123.8 K (+5.54 %) |
Mar 08 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,250 | 12,285 | 92,760 | |
Mar 08 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.90 | 3,250 | 25,675 | 117,313 | 120.6 K to 117.3 K (-2.70 %) |
Mar 08 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,250 | 12,285 | 120,563 | 117.3 K to 120.6 K (+2.77 %) |
Mar 01 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | A | 5.51 | 175,000 | 964,250 | 175,000 | |
Jan 24 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Payment of Exercise | F | 5.95 | 5,198 | 30,928 | 117,313 | 122.5 K to 117.3 K (-4.24 %) |
Jan 03 2017 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Payment of Exercise | F | 6.33 | 1,676 | 10,609 | 122,511 | 124.2 K to 122.5 K (-1.35 %) |
Dec 21 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,250 | 12,285 | 96,010 | |
Dec 21 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.45 | 3,250 | 24,213 | 124,187 | 127.4 K to 124.2 K (-2.55 %) |
Dec 21 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,250 | 12,285 | 127,437 | 124.2 K to 127.4 K (+2.62 %) |
Aug 15 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 5.22 | 4,558 | 23,793 | 124,187 | 128.7 K to 124.2 K (-3.54 %) |
Aug 15 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 5.05 | 1,306 | 6,595 | 128,745 | 130.1 K to 128.7 K (-1.00 %) |
Aug 11 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 4.43 | 14,577 | 64,576 | 130,051 | 144.6 K to 130.1 K (-10.08 %) |
May 25 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | A | 3.22 | 129,427 | 416,755 | 129,427 | |
Mar 03 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Payment of Exercise | F | 2.13 | 465 | 990 | 144,628 | 145.1 K to 144.6 K (-0.32 %) |
Jan 22 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Payment of Exercise | F | 7.55 | 4,823 | 36,414 | 145,093 | 149.9 K to 145.1 K (-3.22 %) |
Jan 21 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 1.42 | 12,500 | 17,750 | 87,500 | |
Jan 21 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 2,500 | 9,450 | 99,260 | |
Jan 21 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 1.42 | 12,500 | 17,750 | 149,916 | 137.4 K to 149.9 K (+9.10 %) |
Jan 21 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 2,500 | 9,450 | 137,416 | 134.9 K to 137.4 K (+1.85 %) |
Jan 05 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Payment of Exercise | F | 10.32 | 1,676 | 17,296 | 134,916 | 136.6 K to 134.9 K (-1.23 %) |
Dec 31 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | A | 10.82 | 62,573 | 677,040 | 62,573 | |
Dec 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 10.86 | 3,052 | 33,145 | 136,592 | 139.6 K to 136.6 K (-2.19 %) |
Dec 18 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 10.49 | 3,000 | 31,470 | 139,644 | 142.6 K to 139.6 K (-2.10 %) |
Jul 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 16.50 | 3,500 | 57,750 | 142,644 | 146.1 K to 142.6 K (-2.39 %) |
Jun 24 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 4.73 | 3,750 | 17,738 | 11,750 | |
Jun 24 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 16.00 | 3,750 | 60,000 | 146,144 | 149.9 K to 146.1 K (-2.50 %) |
Jun 24 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 4.73 | 3,750 | 17,738 | 149,894 | 146.1 K to 149.9 K (+2.57 %) |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,175 | 12,002 | 101,760 | |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,100 | 11,718 | 104,935 | |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,100 | 11,718 | 108,035 | |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 15.00 | 3,175 | 47,625 | 146,144 | 149.3 K to 146.1 K (-2.13 %) |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,175 | 12,002 | 149,319 | 146.1 K to 149.3 K (+2.17 %) |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 15.00 | 3,500 | 52,500 | 146,144 | 149.6 K to 146.1 K (-2.34 %) |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 13.50 | 3,100 | 41,850 | 149,644 | 152.7 K to 149.6 K (-2.03 %) |